The Tennessee Center for AIDS Research CFAR (CFAR) is located in the Southeastern US, the region with both the greatest number of new HIV-1 infections, and of persons living with HIV. Under the leadership of Dr. Simon Mallal, recruited to Vanderbilt (VU) to lead this Center, the Tennessee CFAR is a three-way partnership between a research-intensive institution (VU), a historically black medical college (Meharry Medical College, MMC), and an academically engaged state health department (Tennessee Department of Health, TDH). This CFAR's institutional and community environment is rich in opportunity, and with a culture of engagement and collaboration. The Clinical Sciences Core (CSC) will fill major gaps in the local research environment, and in so doing support the mission of the Tennessee CFAR to reduce the burden of HIV/AIDS, as well as other goals of the nationwide CFAR program. This will be accomplished through three Specific Aims: 1) To propel the use of robust observational databases for hypothesis-driven clinical and translational research across disciplines focused on reducing the overall burden of HIV/AIDS; 2) To support investigators with research projects that require access to study volunteers, and associated biological specimens; 3) To create new opportunities for clinical and translational research at MMC, as well as cross-institutional opportunities, and to facilitate MMC investigator access to such opportunities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI110527-04
Application #
9631978
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Beaubien, Candice M
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Rebeiro, Peter F; Howe, Chanelle J; Rogers, William B et al. (2018) The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States. AIDS Care 30:1426-1434
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Balasubramaniam, Muthukumar; Zhou, Jing; Addai, Amma et al. (2018) PF74 Inhibits HIV-1 Integration by Altering The Composition of the Preintegration Complex. J Virol :
Tan, Yi; Tsan-Yuk Lam, Tommy; Heberlein-Larson, Lea A et al. (2018) Large scale complete genome sequencing and phylodynamic analysis of eastern equine encephalitis virus reveal source-sink transmission dynamics in the United States. J Virol :
Rickles, Michael; Rebeiro, Peter F; Sizemore, Lindsey et al. (2018) Tennessee's In-state Vulnerability Assessment for a ""Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection"" Event Utilizing Data About the Opioid Epidemic. Clin Infect Dis 66:1722-1732
Koethe, John R; McDonnell, Wyatt; Kennedy, Arion et al. (2018) Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons. J Acquir Immune Defic Syndr 77:e14-e21
Stone Jr, Cosby A; Liu, Yiwei; Relling, Mary V et al. (2018) Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract :
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Leger, Paul; Chirwa, Sanika; Nwogu, Jacinta N et al. (2018) Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation. Pharmacogenet Genomics 28:1-6
Trubiano, Jason A; Strautins, Kaija; Redwood, Alec J et al. (2018) The Combined Utility of Ex Vivo IFN-? Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. J Allergy Clin Immunol Pract 6:1287-1296.e1

Showing the most recent 10 out of 126 publications